 |
Maas Biolab Wins World Cyclosporin Brain Formula Patents
February 9, 2011
|
|
Maas Biolab Decreases Holdings in NeuroVive Pharmaceutical
September 21, 2010
|
|
Maas Biolab SBIR Enters Phase 2 for Cyclosporin ALS Treatment
December 3, 2008 |
|
Maas Biolab Scientists Validate Cyclosporin Human Neuroprotection
November 17, 2008 |
|
Maas Biolab Subsidiary NeuroVive Pharmaceutical Raises $1.5 Million in Swedish Public Offering
October 3, 2008 |
|
New Mexico Economic Development Department: Maas BiolAB Awarded $2.1 Million SBIR
October 24, 2007 |
|
Maas BiolAB Awarded $2.1 Million SBIR for Cyclosporin ALS Treatment
October 11, 2007 |
|
Maas BiolAB Presents to Investor Forum
May 7, 2007 |
|
TEDCO Awards Four Companies a Total of $200,000 from Ft. Detrick Technology Transfer Initiative
May 2, 2007 |
|
Lundaforskning om skydd mot nervgasskador (Lund Research Protects Against Nerve Gas Damage)
(Lund University, Sweden) February 7, 2007 |
|
Maas BiolAB Awarded Department of Defense/DTRA Contract
(BUSINESS WIRE) February 5, 2007 |
|
Two New Compounds Target Cell Death by Mitochondria
(MDA/ALS Newsmagazine) v12 n2 February 2007 |
